Nanchang, China

Lianqun Wang

This inventor holds 1 USPTO granted patent. Top assignees: Jiangxi Leyun Health Technology Co., Ltd, The First Affiliated Hospital of Guangzhou Medical University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lianqun Wang. Retrieved from https://idiyas.com/inventor/lianqun-wang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lianqun Wang: Innovator in Neurodegenerative Disease Treatment

Introduction

Lianqun Wang is a notable inventor based in Nanchang, China. He has made significant contributions to the field of medical technology, particularly in the treatment of neurodegenerative diseases. His innovative approach has garnered attention in the medical community.

Latest Patents

Lianqun Wang holds a patent for a "Modified Hemofiltration Method for Clearing Peripheral α-synuclein Aggregates in Patients with Neurodegenerative Disease." This patent represents a crucial advancement in the treatment of conditions associated with neurodegeneration.

Career Highlights

Throughout his career, Lianqun Wang has worked with esteemed institutions such as the First Affiliated Hospital of Guangzhou Medical University and Jiangxi Leyun Health Technology Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative methods.

Collaborations

Lianqun Wang has collaborated with notable colleagues, including Xiang Chen and Mingshu Mo. These partnerships have contributed to the advancement of his research and the successful implementation of his patented methods.

Conclusion

Lianqun Wang's contributions to the field of neurodegenerative disease treatment through his innovative patent highlight his role as a significant inventor. His work continues to impact the medical community positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…